Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD
Public ClinicalTrials.gov record NCT06192004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational, Prospective, Multicenter Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD
Study identification
- NCT ID
- NCT06192004
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 83 participants
Conditions and interventions
Conditions
Interventions
- None (Observational Study) Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 4, 2024
- Primary completion
- Apr 29, 2025
- Completion
- Apr 29, 2025
- Last update posted
- May 3, 2026
2024 – 2025
United States locations
- U.S. sites
- 23
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Los Angeles | California | 90027 | — |
| Research Site | Los Angeles | California | 90033 | — |
| Research Site | Denver | Colorado | 80204 | — |
| Research Site | Golden | Colorado | 80222 | — |
| Research Site | Miami Lakes | Florida | 33014 | — |
| Research Site | Skokie | Illinois | 60076 | — |
| Research Site | Ames | Iowa | 50010-3014 | — |
| Research Site | Covington | Louisiana | 70433 | — |
| Research Site | Troy | Michigan | 48098 | — |
| Research Site | Florham Park | New Jersey | 07932 | — |
| Research Site | Mickleton | New Jersey | 08056 | — |
| Research Site | Shirley | New York | 11967 | — |
| Research Site | Westbury | New York | 11590 | — |
| Research Site | Canton | Ohio | 44708 | — |
| Research Site | Canton | Ohio | 44710 | — |
| Research Site | Cincinnati | Ohio | 45219 | — |
| Research Site | Massillon | Ohio | 44646 | — |
| Research Site | York | Pennsylvania | 17403 | — |
| Research Site | Austin | Texas | 78745 | — |
| Research Site | Dallas | Texas | 75246 | — |
| Research Site | Houston | Texas | 77024 | — |
| Research Site | Longview | Texas | 75601 | — |
| Research Site | Odessa | Texas | 79902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06192004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2026 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06192004 live on ClinicalTrials.gov.